GlobeNewswire by notified

Infant Bacterial Therapeutics today announces new patent protection approvals in Brazil and in Hong Kong

Share

Infant Bacterial Therapeutics AB today announces that the Patent Offices of Brazil and Hong Kong have approved a patent of Lactobacillus reuteri covering IBP-9414. IBT is currently developing its drug candidate IBP-9414 in Phase III for the prevention of necrotizing colitis and improvement of feeding tolerance in preterm infants.

The patent covers a novel way to activate the bacteria. Corresponding patent applications are currently pending across several important future markets. This patent reinforces the existing protection of IBT’s drug candidate IBP-9414. Additional market protection, beyond patent exclusivity, is also anticipated in the form of Orphan Drug Exclusivity and biological data protection in the US and EU.

The patent provides coverage until 2036. IBP-9414 is intended to be marketed in Brazil and Hong Kong upon marketing authorization.

“We are pleased to have strengthened our intellectual property protection for IBP-9414 through the approved patents in Brazil and Hong Kong. Brazil is in particular a substantial market with about 215 million inhabitants, which makes it a very interesting commercial opportunity for our future product", states CEO Staffan Strömberg, IBT.

About Infant Bacterial Therapeutics AB

Infant Bacterial Therapeutics AB (IBT) is a public company domiciled in Stockholm. The company’s Class B shares are listed on Nasdaq Stockholm, Mid-cap (IBT B).

Infant Bacterial Therapeutics AB (publ) (IBT) is a pharmaceutical company with a product in clinical phase III with a vision to develop drugs influencing the infant microbiome, and thereby prevent or treat rare diseases affecting infants.

IBT is currently developing the drug candidate IBP-9414. The ambition for IBP-9414 is to become the world’s first approved probiotical drug with the goal to prevent life threatening diseases in premature infants including NEC and sepsis by promoting healthy stomach-and bowel development in premature infants. IBP-9414 contains the active compound Lactobacillus reuteri, which is a human bacterial strain naturally present in breast milk. The product portfolio also includes another project, IBP-1016, for the treatment of gastroschisis, a severe and rare disease affecting infants. By developing these drugs, IBT has the potential to fulfill unmet needs for diseases where there are currently no prevention or treatment therapies available.

For additional information please contact

Staffan Strömberg, CEO
Infant Bacterial Therapeutics AB
Bryggargatan 10
111 21 Stockholm
Telefon: +46 8 410 145 55
info@ibtherapeutics.com
www.ibtherapeutics.com

Publication

This information is information that Infant Bacterial Therapeutics AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 22:30 CET on 27 December 2021.

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Share Buyback Transaction Details January 20 – 26, 202227.1.2022 10:00:00 CET | Press release

Share Buyback Transaction Details January 20 – 26, 2022 January 27, 2022 - Wolters Kluwer today reports that it has repurchased 78,099 of its own ordinary shares in the period from January 20, 2022, up to and including January 26, 2022, for €6.9 million and at an average share price of €88.92. These repurchases are part of the share buyback program announced on November 3, 2021, under which we intend to repurchase shares for €50 million during the period starting January 3, 2022, up to and including February 21, 2022. The cumulative amounts repurchased to date under this program are as follows: Share Buyback 2022 PeriodCumulative shares repurchased in period Total consideration (€ million)Average share price (€) 2022 to date 265,483 25.0 94.18 For the above-mentioned period, we have engaged a third party to execute €50 million of buybacks on our behalf, within the limits of relevant laws and regulations (in particular Regulation (EU) 596/2014) and the company’s Articles of Association.

Cool Company Limited Update27.1.2022 09:14:12 CET | Press release

27 January 2022; Golar LNG (“Golar”) is pleased to provide a further update on the formation of Cool Company Ltd. (“CoolCo”). Reference is made to announcements on 15 December 2021 and 20 January 2022, regarding Golar’s announced execution of a Terms Agreement to separate its 8 TFDE LNG carriers into CoolCo. Based on investor feedback following the press releases made on 15 December 2021 and 20 January 2022, CoolCo has decided to launch a book building process of a private placement of $250 million (“The Private Placement”). The anticipated proceeds from the Private Placement will, together with a contemplated debt refinancing, be used to finance the acquisition of the 8 TFDE vessels from Golar, secure attractive financing and provide CoolCo with working capital to position the company for further growth. Eastern Pacific Shipping (“EPS”) has pre-subscribed and guaranteed an allocation of minimum $150 million in the contemplated private placement. The Private Placement The Private Place

Hitachi Energy achieves 100% fossil free electricity in own operations27.1.2022 09:00:00 CET | Press release

The global technology and market leader in power grids has achieved the first-step target in its Sustainability 2030 plan and steps up the pace towards carbon-neutral Zurich, Switzerland, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Hitachi Energy today announced that it has achieved the first-step target set out in its Sustainability 2030 plan – the use of 100% fossil-free electricity in its own operations1. The company is driving towards being carbon-neutral in its own operations by 20302, in line with its Purpose, ‘Advancing a sustainable energy future for all’. “By achieving 100% fossil-free electricity in our own operations, we have reduced our CO2 equivalent emissions by over 50% compared to 2019,” says Claudio Facchin, CEO of Hitachi Energy. He continued, “The Net Zero challenge is global and it’s about acting now, innovating and collaborating across countries, industries and societies. Together with customers, partners, and all stakeholders, we are advancing the world’s energy system to b

Participation notification by Blackrock Inc.27.1.2022 08:30:00 CET | Press release

Participation notification by Blackrock Inc. Brussels, 27 January 2022, 08:30 CET - According to Belgian transparency legislation (Law of May 2, 2007), BlackRock Inc. (55 East 52nd Street, New York, NY, 10055, U.S.A.) recently sent to Solvay the following transparency notifications indicating that it crossed the threshold of 3%. Here is a summary of the moves: Date on which the threshold was crossed Voting rights after the transaction Equivalent financial instruments after the transaction Total January 21, 2022 3.05% 0.41% 3.46% January 24, 2022 2.93% 0.44% 3.37% The latest notification, dated January 25, 2022, contains the following information: Reason for the notification: acquisition or disposal of voting securities or voting rightsNotified by: BlackRock Inc. (55 East 52nd Street, New York, NY, 10055, U.S.A.)Date on which the threshold is crossed: January 24, 2022Threshold of direct voting rights crossed: 3% downwardsDenominator: 105,876,416Additional information: The disclosure obl

Van Lanschot Kempen prepares additional covered bond programme27.1.2022 08:30:00 CET | Press release

’s-Hertogenbosch/Amsterdam, the Netherlands, 27January 2022 Van Lanschot Kempen is working on creating an additional covered bond programme with a soft bullet structure in 2022, under which any future covered bonds are expected to be issued. The new programme will allow further diversification of Van Lanschot Kempen’s debt investor base and funding profile. Media Relations: +31 203544585; mediarelations@vanlanschotkempen.com Investor Relations: +31 203544590; investorrelations@vanlanschotkempen.com About Van Lanschot Kempen Van Lanschot Kempen, a wealth manager active in Private Banking, Asset Management and Merchant Banking, aims to preserve and create wealth, in a sustainable way, for both its clients and the society of which it is part. Listed at Euronext Amsterdam, Van Lanschot Kempen is the Netherlands’ oldest independent financial services company, with a history dating back to 1737. For more information, please visit vanlanschotkempen.com This press release does not constitute a

Stolt-Nielsen Limited Reports Unaudited Results For the Fourth Quarter and Full Year 202127.1.2022 08:15:00 CET | Press release

LONDON, January 27, 2022 – Stolt-Nielsen Limited (Oslo Børs: SNI) today reported unaudited results for the fourth quarter and full year 2021. The Company reported a fourth-quarter net profit of $35.0 million, with revenue of $593.1 million, compared with a net profit of $33.5 million, with revenue of $580.9 million, in the third quarter. The net profit for the full year 2021 was $78.8 million, with revenue of $2,181.1 million, compared with a net profit from continuing operations of $39.2 million, with revenue of $1,955.1 million, in 2020. Highlights for the fourth quarter, compared with the third quarter of 2021, were: Stolt Tankers reported operating profit of $19.2 million, down from $24.1 million due to weaker COA volumes and rising voyage expenses. The Stolt Tankers Joint Service (STJS) Sailed-in Time-Charter Index reduced slightly from 0.53 to 0.51. The STJS sailed-in revenue for the quarter was $18,438 per operating day basis an average size per ship of 31,694 deadweight tonnes

PGS ASA: Q4 and Preliminary Full Year 2021 Results27.1.2022 08:00:00 CET | Press release

Improving Competitive Position in a Gradually Recovering Market Takeaways 2021 Segment Revenues and Other Income of $590.0 million, compared to $595.9 million in 2020, which included $38.8 million of Covid-19 related government grantsSegment EBITDA of $320.2 million, compared to $397.7 million in 2020, impacted by a significant change of activity mix with less MultiClient and more contract acquisitionSegment EBIT loss (excluding impairments and other charges) of $54.6 million, compared to a profit of $12.2 million in 2020Cash flow from operations of $326.6 million, compared to $366.5 million in 2020Returning to positive net cash flow generation in 2021, with cash flow before financing activities (interest payments and debt service) of $154.7 million for the full year As Reported Revenues and Other Income according to IFRS of $703.8 million and an EBIT loss of $66.2 million, compared to $512.0 million and an EBIT loss of $188.0 million, respectively, in 2020Leveraging PGS’ integrated bu